Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Business Models and Strategy

 

Al Borg eyes franchising and reference markets

Big Saudi lab group Al Borg plans to use franchising to grow rapidly with a consumer-led offer which includes imaging and primary care. It is also constructing two enormous reference labs in Riyad and Jeddah with the aim of seizing a market where Saudi spends billions.  The group is also still eyeing a stock market listing.
January 30, 2023

HCA launches one number, ambulance backed acute admission service

Hospital group HCA UK has launched a 24/7 concierge and ambulance service to ease acute admissions to its four London hospitals. It says it has seen over 100% revenue growth in the last year as a result. Is it trying to provide an alternative to the crowded NHS A&E departments across the country? HBI investigates.   
January 27, 2023

Fleeing freelancers cause headache for Dutch elderly care groups

Nursing home employees in the Netherlands are fleeing full-time, permanent jobs in droves in pursuit of more lucrative and flexible alternatives. As operators facing stiff competition from digital freelance platforms poaching their labourforce, HBI speaks to three Dutch market experts to better understand the threat. 
January 26, 2023

AXA IM debuts in Spain with ESG nursing home deal

Global investment manager AXA IM Alts (the alternative investment arm of AXA IM) has joined forces with Spanish real estate investor Grupo Lar to invest in Spanish health care real estate assets, marking its launch into the Spanish health care market. 
January 20, 2023

Interview: Richard Storah, CFO, mydentist

HBI chats with mydentist CFO Richard Storah about the UK-based dental group’s history, its plans for 2023 and beyond, and how he sees the post-pandemic market.
January 19, 2023

Sanoptis targets Spain for expansion

Sanoptis, Germany’s second largest ophthalmology group by revenue, is looking to expand in Spain, and beyond, and looking at targets to buy.
January 13, 2023

Eight predictions for for-profit health care in 2023

2022 was a tumultuous year for for-profit health care. The year began with a sense of things returning to a new normal, after the major disruption of the Covid pandemic throughout 2020 and 2021. But then, not even two months in, Russia invaded Ukraine, and this quickly led to an energy and economic crisis throughout Europe. For the first time in decades inflation reached double-digit figures across almost every OECD country and the era of near-zero interest rates came to an abrupt end. The second half of the year saw major worries about a looming recession and a potential debt crisis, rapidly falling investment and M&A deal volumes slowing to almost a standstill.
January 6, 2023

Portuguese competition authority goes after labs

Portugal’s competition authority (AdC) has opened an investigation into collusion it suspects took place between several of the country’s major labs groups during the years 2016 and 2022. The accused groups include Affidea, Synlab and Unilabs subsidiaries.
January 6, 2023
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us